Hasegawa Kiyoshi, Takemura Nobuyuki, Yamashita Tatsuya, Watadani Takeyuki, Kaibori Masaki, Kubo Shoji, Shimada Mitsuo, Nagano Hiroaki, Hatano Etsuro, Aikata Hiroshi, Iijima Hiroko, Ueshima Kazuomi, Ohkawa Kazuyoshi, Genda Takuya, Tsuchiya Kaoru, Torimura Takuji, Ikeda Masafumi, Furuse Junji, Akahane Masaaki, Kobayashi Satoshi, Sakurai Hideyuki, Takeda Atsuya, Murakami Takamichi, Motosugi Utaroh, Matsuyama Yutaka, Kudo Masatoshi, Tateishi Ryosuke
Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Department of Surgery, Hepato-Biliary Pancreatic Surgery Division, National Center for Global Health and Medicine, Tokyo, Japan.
Hepatol Res. 2023 May;53(5):383-390. doi: 10.1111/hepr.13892. Epub 2023 Mar 10.
The fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine and partly to the Grading of Recommendations Assessment, Development and Evaluation system, which was published in October 2021 in Japanese. In addition to surveillance-diagnostic and treatment algorithms, a new algorithm for systemic therapy has been created, as multiple drugs for hepatocellular carcinoma can be currently selected. Here, new or revised algorithms and evidence on which the recommendations are based are described.
日本肝脏学会依据循证医学方法并部分参照推荐分级的评估、制定与评价系统，修订了《肝细胞癌临床实践指南》第5版，该指南于2021年10月以日语发布。除了监测诊断和治疗算法外，鉴于目前可选择多种用于肝细胞癌的药物，还创建了一种新的全身治疗算法。在此，将介绍新的或修订的算法以及作为推荐依据的证据。
Zotero 插件